INTERRELATIONSHIP BETWEEN EFFICIENCY OF CANCER TREATMENT AND STATE OF IMMUNE SYSTEM IN PATIENTS WITH LARYNGEAL AND HYPOPHARYNGEAL CANCER

Código QR

INTERRELATIONSHIP BETWEEN EFFICIENCY OF CANCER TREATMENT AND STATE OF IMMUNE SYSTEM IN PATIENTS WITH LARYNGEAL AND HYPOPHARYNGEAL CANCER

Abstract. We have studied possible interrelationships between immune system state and efficiency of neoadjuvant chemoradiotherapy in patients with cancer of larynx and hypopharynx. The neoadjuvant treatment consisted of 2 courses of paclitaxel (175 mg/m2), carboplatin (AUC-6 in 3-4 weeks), followed...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	M. N. Stakheyeva, E. L. Choinzonov, S. Yu. Chizhevskaya, V. A. Bychkov
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	immune system head and neck cancer antitumor treatment efficiency Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/06ec0286b2de4157948308994b1c65dd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment
por: Glauco Akelinghton Freire Vitiello, et al.
Publicado: (2021)

IMMUNE PARAMETERS AND LYMPHOCYTE-PLATELET ADHERENCE IN LARYNGEAL CARCINOMA
por: Yu. A. Vitkovsky, et al.
Publicado: (2014)

ANTICANCER DNA VACCINATION: PRINCIPLE AND PERSPECTIVES OF THE METHOD
por: M. V. Stegantseva, et al.
Publicado: (2017)

THE INDIVIDUAL DIFFERENCE OF ABILITY BINDING BRAIN TUMOR CELLS WITH IMMUNOGLOBULIN G
por: O. V. Ostreiko, et al.
Publicado: (2014)

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response
por: Margaux Vienne, et al.
Publicado: (2021)

Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
por: Shalini K. Sureshbabu, et al.
Publicado: (2021)

PENTOXIFYLLINE ENHANCES IN VITRO T-CELL ANTITUMOR RESPONSE IN BREAST CANCER PATIENTS
por: M. S. Kuznetsova, et al.
Publicado: (2021)

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
por: Zhihui Zhang, et al.
Publicado: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qi Sun, et al.
Publicado: (2021)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Yilmaz B, et al.
Publicado: (2021)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

TUMOR-SPECIFIC IMMUNE RESPONSE AFTER PHOTODYNAMIC THERAPY
por: Yu. N. Anokhin, et al.
Publicado: (2016)

EFFICIENCY AND SAFETY OF MELATONIN ADMINISTRATION IN THE PATIENTS WITH ATOPIC DERMATITIS
por: V. S. Shirinsky, et al.
Publicado: (2014)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
por: Xinwen Wang, et al.
Publicado: (2021)

Anti-PD-1 Therapy—A Potential Treatment for Myocardial Metastasis From Nasopharyngeal Carcinoma: A Case Report
por: Xiaowan Tang, et al.
Publicado: (2021)

SPECIFIC IMMUNOTHERAPY AND CELLULAR IMMUNITY IN PATIENTS WITH CERVICAL CANCER
por: D. K. Kenbaeva, et al.
Publicado: (2014)

Cáncer de cabeza y cuello: validación de cuestionario QLQ-H&N35
por: Carcamo,Marcela, et al.
Publicado: (2018)

EFFICACY OF IMMUNOMODULATORS AND ANTIOXIDANTS IN THE CORRECTION OF IMPAIRED IMMUNE STATUS PARAMETERS IN PATIENTS WITH ADENOMYOSIS
por: O. Yu. Ivanova, et al.
Publicado: (2021)

Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion
por: Wang Gong, et al.
Publicado: (2021)

STATE OF IMMUNE SYSTEM IN PATIENTS WITH PRIMARY HEADACHES
por: M. I. Karpova, et al.
Publicado: (2014)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
por: A. V. Bogolyubova, et al.
Publicado: (2015)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
por: Anisha Gehani, et al.
Publicado: (2021)

The HSP Immune Network in Cancer
por: Zarema Albakova, et al.
Publicado: (2021)

EVALUATION OF CELLULAR IMMUNE RESPONSE DURING XENOVACCINE THERAPY OF THE PATIENTS WITH STAGE IV OF COLORECTAL CANCER
por: M. A. Felde, et al.
Publicado: (2014)

Importance of cellular immunity link for efficiency of replacement therapy in common variable immune deficiency
por: L. P. Sizyakina, et al.
Publicado: (2020)

Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence
por: Haoxin Peng, et al.
Publicado: (2021)

When Everything Revolves Around Internal Carotid Artery: Analysis of Different Management Strategies in Patients With Very Advanced Cancer Involving the Skull Base
por: Ester Orlandi, et al.
Publicado: (2021)

Phenotypic and functional changes of NK cells in patients with myelodysplastic syndrome and acute myeloid leukemia treated with hypomethylating drugs
por: D. I. Zhigarev, et al.
Publicado: (2021)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Adam Luginbuhl, et al.
Publicado: (2021)

INFECTION AND IMMUNITY: STRATEGIES FROM BOTH SIDES
por: G. F. Zheleznikova
Publicado: (2014)

CHANGES OF IMMUNE STATUS IN WOMEN WITH MISSED ABORTION
por: T. V. Vavilova, et al.
Publicado: (2014)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
por: Zhao-Cong Zhang, et al.
Publicado: (2021)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
por: Hayashi N, et al.
Publicado: (2021)

EFFECTS OF INTERFERON THERAPY UPON IMMUNE MARKER PROFILE AND ENZYMATIC ACTIVITY IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH RENAL CANCER
por: L. M. Kurtasova, et al.
Publicado: (2014)

SYNOPSIS AND PROSPECTS OF AUTOIMMUNOLOGY DEVELOPMENT WORLDWIDE (AFTER THE MATERIALS OF THE 11th INTERNATIONAL CONGRESS IN LISBON, MAY 16-20, 2018). PROCEEDING I: FIRST ACADEMY OF AUTOIMMUNITY
por: E. A. Korneva, et al.
Publicado: (2019)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Shinsuke Suzuki, et al.
Publicado: (2021)

COMBINATION ANALYSIS OF CYTOKINE GENE PROMOTER POLYMORPHISMS OF IL1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL4 C-590T, IL-10 C-592A FOR PREDICTION OF TREATMENT EFFICIENCY IN RHEUMATOID ARTHRITIS
por: V. I. Konenkov, et al.
Publicado: (2014)

CLINICAL CHARACTERIZATION OF FUNCTIONAL DISORDERS AFFECTING IMMUNE SYSTEM
por: A. G. Borisov
Publicado: (2014)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Jingjing Wang, et al.
Publicado: (2021)

IL–18 AND IMMUNITY
por: E. V. Yakushenko, et al.
Publicado: (2014)